News

October 30, 2019

Celebs in Parody Video Urge Support for Movember to Raise Prostate Cancer Awareness

News

In a lighthearted twist on a serious goal of raising awareness and funds for prostate cancer, the Movember Foundation is again encouraging gents to join glitterati in celebrating the moustache. ... Read more

October 28, 2019

Targeted Radiation (SBRT) Can Control Prostate Cancer That Has Spread Slightly, Trial Results Suggest

News

Stereotactic body radiation therapy (SBRT) — a form of targeted, high-dose radiation therapy — significantly extends the time without detectable disease progression when given to prostate cancer patients with limited ... Read more

October 24, 2019October 25, 2019

Prostate Cancer Patients May Safely Skip Radiation Therapy After Surgery, Phase 3 Trial Shows

News

Men with prostate cancer who undergo surgery have similar long-term outcomes whether they receive radiation therapy shortly after the surgery or only when signs of disease recurrence appear, suggesting that ... Read more

October 23, 2019

FDA Grants Breakthrough Device Designation to IsoPSA Blood Test for Early Prostate Cancer Diagnosis

News

The U.S. Food and Drug Administration (FDA) has granted breakthrough device designation to Cleveland Diagnostics’ IsoPSA, a minimally invasive blood test for early detection of prostate cancer. The IsoPSA test ... Read more

October 21, 2019

Radiotherapy Plans Based on Machine Learning Being Used to Treat Localized PC Patients

News

Radiotherapy plans generated with machine learning in the RayStation system are now being used at the Princess Margaret Cancer Centre, in Canada, to treat men with localized prostate cancer. RayStation ... Read more

October 17, 2019

Erleada-ADT Combo Increases Survival of mCSPC Patients Without Affecting Quality of Life, Phase 3 Trial Shows

News

Adding Erleada (apalutamide) to standard androgen deprivation therapy (ADT) increases the survival and delays disease progression in men with metastatic castration-sensitive prostate cancer (mCSPC) — and does so without compromising ... Read more

October 16, 2019October 25, 2019

Long-term Hormone Therapy Does More Harm than Good in Prostate Cancer Patients with Low PSA Levels After Surgery, Analysis Shows

News

Men who see their prostate cancer returning after surgery see no benefits from adding long-term hormone therapy to salvage radiation therapy if their PSA levels are low; instead, they might ... Read more

October 14, 2019October 14, 2019

Liproca Depot Shows Promise for Treatment of Early-Stage Prostate Cancer

News

A new injectable flutamide formulation called Liproca Depot is safe, well-tolerated and shows sustained efficacy in untreated men with localized prostate cancer, according to early results of a Phase 2b clinical ... Read more

October 10, 2019

$35M Gift from Benioffs to Support Prostate Cancer Research Initiative at UCSF

News

A $35 million gift from Marc and Lynne Benioff will support a new initiative at the University of California, San Francisco (UCSF) aimed at finding personalized treatments for prostate cancer. ... Read more

October 9, 2019

Zejula Granted FDA’s Breakthrough Therapy Status for Treating Metastatic Castration-resistant Prostate Cancer

News

The oral ovarian cancer treatment Zejula (niraparib) has been given Breakthrough Therapy status by the U.S. Food and Drug Administration (FDA) for the treatment of men with metastatic castration-resistant prostate ... Read more